BioCentury
ARTICLE | Company News

Critical Pharmaceuticals, University of Nottingham deal

February 27, 2012 8:00 AM UTC

The university and Critical Pharmaceuticals partnered to develop an intranasal formulation of teriparatide to treat osteoporosis. The university's Technology Strategy Board and the Engineering and Physical Sciences Research Council (EPSRC) will provide a grant for the project, which Critical says is valued at £545,000 ($863,880). Details were not disclosed. ...